Three years of experience with total hip replacement.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000601:surgery; D005260:Female; D005264:Femoral Fractures / Q000209:etiology; D005500:Follow-Up Studies; D005768:Gastrointestinal Hormones / Q000209:etiology; D006406:Hematoma / Q000209:etiology; D006615:Hip / Q000601:surgery*; D006617:Hip Dislocation / Q000209:etiology; D006621:Hip Joint; D006801:Humans; D007049:Iatrogenic Disease / Q000209:etiology; D007595:Joint Prosthesis / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009999:Ossification, Heterotopic / Q000209:etiology; D010003:Osteoarthritis / Q000601:surgery; D011183:Postoperative Complications; D013923:Thromboembolism / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005768:Gastrointestinal Hormones; D014859:Warfarin